Free. Unsubscribe any time.
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARROWHEAD PHARMACEUTICALS, INC. filed 23 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 10 reporting owners, covering 62 transactions and 740,162 shares. None carries the SEC's AFF10B5ONE flag; all 23 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-05-14, came 20 days after the one before it (2026-04-24) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 2,970 shares, 7,030 fewer than the 10,000 in the filing before it.
- Its 23 plan statements rank 260th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 23 filings on file run from 2025-01-06 to 2026-05-14, and state no plan adoption date.
Trades in ARROWHEAD PHARMACEUTICALS, INC. 62
- Anzalone Christopher Richard — 2025-01-02 · S · 11,520 shares
- Hamilton James C — 2025-01-06 · S · 21,758 shares
- Hamilton James C — 2025-01-06 · S · 10,971 shares
- Myszkowski Kenneth Allen — 2025-01-06 · S · 17,765 shares
- Myszkowski Kenneth Allen — 2025-01-06 · S · 9,402 shares
- O'Brien Patrick — 2025-01-06 · S · 19,658 shares
- O'Brien Patrick — 2025-01-06 · S · 9,526 shares
- Myszkowski Kenneth Allen — 2025-01-07 · S · 8,000 shares
- Myszkowski Kenneth Allen — 2025-01-07 · S · 10,000 shares
- O'Brien Patrick — 2025-01-07 · S · 8,000 shares
- OLUKOTUN ADEOYE Y — 2025-01-23 · S · 959 shares
- Anzalone Christopher Richard — 2025-03-03 · S · 166,667 shares
Adoption dates in ARROWHEAD PHARMACEUTICALS, INC. 0
Results prints in ARROWHEAD PHARMACEUTICALS, INC. 7
- 2025-02-10
- 2025-05-12
- 2025-08-07
- 2025-11-25
- 2026-02-05
- 2026-05-07
- 2026-08-04
Trades before a print in ARROWHEAD PHARMACEUTICALS, INC. 0
- 14 days before the 2026-05-07 print — 2026-04-23 · S · Hamilton James C · 10,000 shares
- 15 days before the 2026-05-07 print — 2026-04-22 · S · Apel Daniel Joseph · 3,208 shares
- 15 days before the 2026-05-07 print — 2026-04-22 · S · Apel Daniel Joseph · 1,157 shares
- 15 days before the 2026-05-07 print — 2026-04-22 · S · Apel Daniel Joseph · 8,730 shares
- 18 days before the 2025-02-10 print — 2025-01-23 · S · OLUKOTUN ADEOYE Y · 959 shares
- 31 days before the 2026-02-05 print — 2026-01-05 · S · Hamilton James C · 4,625 shares
- 31 days before the 2026-02-05 print — 2026-01-05 · S · Hamilton James C · 6,090 shares
- 31 days before the 2026-02-05 print — 2026-01-05 · S · Hamilton James C · 14,792 shares
- 31 days before the 2026-02-05 print — 2026-01-05 · S · Hamilton James C · 12,711 shares
- 31 days before the 2026-02-05 print — 2026-01-05 · S · Hamilton James C · 1,200 shares
- 31 days before the 2026-02-05 print — 2026-01-05 · S · Hamilton James C · 437 shares
- 31 days before the 2026-02-05 print — 2026-01-05 · S · Hamilton James C · 309 shares
Interval to ARROWHEAD PHARMACEUTICALS, INC.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 14shortest, days
- 0no later print
Reported results dates on file
- 2025-02-10
- 2025-05-12
- 2025-08-07
- 2025-11-25
- 2026-02-05
- 2026-05-07
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- GILEAD SCIENCES, INC. 65
Sources: SEC EDGAR full-text search and the SEC submissions API.